Cidofovir and experimental herpetic stromal disease

Archives of Ophthalmology

Volumn 117, Issue 7, 1999, Pages 925-928

  Kaufman, Herbert E ^a   Varnell, Emily D ^a,b   Thompson, Hilary W ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FLUOROMETHOLONE; TRIFLURIDINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; FEMALE; HERPES SIMPLEX VIRUS 1; KERATITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STRAIN DIFFERENCE; TREATMENT OUTCOME;

EID: 0032808572     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.7.925     Document Type: Article

References (19)

1. McNeill JI, Kaufman HE. Local antivirals in a herpes simplex stromal keratitis model. Arch Ophthalmol. 1979;97:727-729.
2. De Clercq E, Sakuma T, Baba M, et al. Antiviral activity of phosphonyl-methoxyalkyl derivatives of purine and pyrimidines. Antiviral Res. 1987;8:261-272.
3. Gordon YJ, Romanowski EG, Araullo-Cruz T. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Invest Ophthalmol Vis Sci. 1994;35:4135-4143.
4. Gordon YJ, Naesens L, De Clercq E, Maudgal PB, Veckeneer M. Treatment of adenoviral conjunctivitis with topical cidofovir [letter]. Cornea. 1996;15:546.
5. Gordon YJ, Romanowski EG, Araullo-Cruz T. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model. Cornea. 1994; 13:516-520.
6. Kaufman HE, Varnell ED, Thompson HW. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Arch Ophthalmol. 1998;116: 777-780.
7. Davis JL, Taskintuna I, Freeman WR, Weinberg DV, Feuer WJ, Leonard RE. Iritis and hypotony after treatment with intravenous cidofovirfor cylomegalovirus retinitis. Arch Ophthalmol. 1997;115:733-737.
8. Barrier JH, Bani-Sadr F, Gaillard F, Raffi F. Recurrent iritis after intravenous administration of cidofovir. Clin Infect Dis. 1997;25:337-338.
9. Friedberg DN. Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis. Arch Ophthalmol. 1997;115:801-802.
10. Banker AS, Arevalo JF, Munguia D, et al. Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis. Am J Ophthalmol. 1997;124:168-180.
11. Chavez-de la Paz E, Arevalo JF, Kirsch LS, et al. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Ophthalmology. 1997;104:539-544.
12. Taskintuna I, Rahhal FM, Arevalo JF, et al. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1997;104:1049-1057.
13. Taskintuna I, Rahhal FM, Rao NA, et al. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS). Ophthalmology. 1997;104:1827-1837.
14. Akler ME, Johnson DW, Burman WJ, Johnson SC. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology. 1998;105:651-657.
15. Taskintuna I, Banker AS, Rao NA, et al. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects. Exp Eye Res. 1997;64: 795-806.
16. Banker AS, Bergeron-Lynn G, Keefe KS, De Clercq E. Effects of topical and subconjunctival cidofovir (HPMPC) in an animal model. Curr Eye Res. 1998;17:560-566.
17. Otova B, Votruba I, Holy A. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonomethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect. Acta Virol. 1992;36:313-319.
18. Soike KF, Huang J-L, Zhang J-Y, Bohm R, Hitchcock MJM, Martin JC. Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-phosphonomethoxy) propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys. Antiviral Res. 1991;16:17-28.
19. SAS Institute Inc. SAS Language Reference, Version 6. Cary, NC: SAS Institute Inc; 1990.